News

21 Nov 2022
221121 AT85 ITF

AT85 Global Mid-Market Infrastructure Income issues ITF

AT85 Global Mid-Market Infrastructure Income Plc (AT85) has as issued an intention to float (ITF) this morning, in which it has announced plans for an initial public offering (IPO) for a premium main market listing on the London Stock Exchange, targeting a capital raise of £300m. The IPO includes a placing to institutional investors; an […]

21 Nov 2022

NextEnergy Solar grows NAV and outperforms generation budget

NextEnergy Solar Fund (NESF) has published its interim results for the six months ended 30 September 2022. The period saw NESF’s NAV per share increase by 8.3% to 122.9p, up from 113.5p as at 31 March 2022. The main contributors to the increase in the NAV were an increase in power price forecast assumptions (+12.0p […]

21 Nov 2022

NB Global Monthly Income proposes managed wind down

NB Global Monthly Income (NBMI) has announced that, following a review of its strategy and future prospects, its Board has decided not to implement its semi-annual cash exit facility in December 2022 but instead to put forward proposals for approval by shareholders to place the company into a managed wind-down. Wind-down triggered by NAV dropping […]

21 Nov 2022

BioPharma Credit provides senior loan to Immunocore

BioPharma Credit (BPCR) has announced that, together with BioPharma Credit Investments V, it has entered into a senior secured loan agreement with Immunocore Limited. BPCR will invest up to US$50m and BioPharma-V will also invest up to an additional US$50m. Based in the UK, Immunocore is a publicly traded biopharmaceutical company with a current market […]

21 Nov 2022

QuotedData’s morning briefing 21 November 2022

In QuotedData’s morning briefing 21 November 2022: Personal Assets (PNL) has published its interim results for the six months ended 31 October 2022. During the period, PNL provided an NAV total return of -3.6%, outperfoming its All-Share benchmark, which it says provided a total return of -5.8%. PNL’s shares continued to trade close to NAV […]

18 Nov 2022

Conviction Life Sciences publishes prospectus for £100m IPO

A new Guernsey domiciled investment company, Conviction Life Sciences (CLSC), published a prospectus on 16 November 2022 for its initial public offering (IPO). The prospectus is availale here. The IPO is targeting gross proceeds of £100m and CLSC plans to list on the main market of the London Stock Exchange. It is expected that CLSC’s […]

16 Nov 2022

QuotedData’s morning briefing 16 November 2022

In QuotedData’s morning briefing 16 November 2022: ThomasLloyd Energy Impact (TLEI/TLEP) has announced the results of its placing that was announced on 8 November 2022. The ‘subsequent placing’ raised gross proceeds of US$35.3m and 34,277,228 new ordinary shares are being issued at a price of US$1.030 (£0.865 being the announced sterling equivalent price) per ordinary […]

14 Nov 2022

QuotedData’s morning briefing 14 November 2022

In QuotedData’s morning briefing 14 November 2022: CT Private Equity Trust (CTPE) sold a portion of its investment in the Italian funeral services business of San Siro and related entities (HOFI S.p.A.) on 10 November 2022. CTPE initially invested in San Siro in January 2019 in a deal led by Augens Capital. This investment has […]

11 Nov 2022

QD view – JLEN Environmental Assets – a world of possibilities!

This week, I had the opportunity to join a capital markets day for JLEN Environmental Assets (JLEN). The event, which was well attended, provided us with a useful update on JLEN’s strategy (which was welcome in light of current market conditions). We also had a presentation from Sten Falkum (CEO of Hima Seafood) and Heidi […]

11 Nov 2022

Inflation correlation – Long Term Assets issues ITF

Long Term Assets Limited (LTA) has issued an intention to float (ITF) this morning, in which it has announced plans for an initial public offering (IPO) on the Specialist Fund Segment of the main market of the London Stock Exchange. LTA says that it will then launch a 12-month placing programme, aimed in particular at […]